In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming ...

AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...

AbbVie sues HHS over Botox Medicare pricing, challenging CMS authority under the Inflation Reduction Act and drug price negotiation rules.

AbbVie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the Centers for Medicare ...

AbbVie (NYSE:ABBV) has filed a lawsuit against the U.S. Department of Health and Human Services over the inclusion of Botox in Medicare price negotiations. The company argues that Botox should be ...

AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its blockbuster anti-wrinkle therapy Botox for the next round of Medicare price ...

Botox first became a household name for its ability to turn back the clock on facial aging. However, if you are considering Botox for cosmetic reasons and expecting Medicare coverage, you’ll be ...

Medicare is negotiating to lower the price of several major drugs aimed at treating chronic conditions, cancers, and autoimmune treatments.

Botox vs fillers compared. Understand cosmetic injectables, treatment differences, and what to expect from today's anti aging ...